Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising outcomes. However, the cost of this innovative drug and its supply have become key issues for patients and healthcare professionals. While tirzepatide has been approved by regulatory agencies, its costly nature presents a significant obstacle to many. Discu